Korea Investment Partners — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
01.AI builds full-stack enterprise and sovereign AI solutions, including foundation models, industry agents, and decision-support applications for CEOs, executives, investment teams, and B2B/government sales organizations.
AI & Machine LearningDeep TechEnterprise SoftwareBeijing, CN
Guoyin Wang(Founder)in
BoardKai-Fu Lee(Founder)in
Co-investorsSinovation VenturesIndex VenturesLux CapitalNew Enterprise Associates (NEA)Quadrille CapitalRadical Ventures
HyperAccel designs AI semiconductors, including its LPU (an AI-specialized processor) and products such as the Bertha 500 chip, Forte 55X accelerator card, and HX-F55X on-premise inference server, aimed at accelerating LLM inference from edge devices to cloud datacenters.
AI & Machine LearningHardwareSemiconductors
Co-investorsAsia2G CapitalLB Investment
Twelve operates AirPlant One, a commercial-scale eManufacturing facility in Moses Lake, Washington, that converts CO2, water, and renewable electricity into products including E-Jet fuel and E-Naphtha, a chemical building block.
CleantechClimate TechNew MaterialsMoses Lake, US
Nicholas Flanders(Cofounder)
Co-investorsDesigner FundGVA CapitalRanch VenturesCapricorn Investment GroupIndex VenturesNew Enterprise Associates (NEA)+2 more
Twelve Labs develops AI technology for video understanding, enabling machines to comprehend and analyze video content for applications in human-machine interaction and perception.
AI & Machine LearningData & InfrastructureMedia & EntertainmentSan Francisco, US
Jae Sung Lee(Executive Officer, Director)Seung Joon Lee(Executive Officer, Director)Jin Woo Chung(Executive Officer, Director)Soyoung Lee(Executive Officer, Director)inAiden L.(Founder)inDong Shin Kim(Director)
Co-investorsExpaHan River PartnersHillspring InvestmentHubSpot VenturesIndex VenturesIntel Capital+12 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.